ABSTRACT

Metabolic syndrome (MS) comprises pathological conditions that includes insulin resistance, arterial hypertension, visceral adiposity and dyslipidemia, which favors the development of cardiovascular diseases and type 2 diabetes (Reaven 1988). Existing evidence suggests that MetS is rising in developed countries and in developing countries (Grundy 2008).